C000091238 Fees and Costs — World ex U.S. Value Portfolio, Institutional Class Shares

Data updated: 2026-09-24

The net expense ratio is 0.37% (0.56% before fee waivers). There are no sales loads or redemption fees. In fiscal 2025 the fund paid $124 in broker commissions, and portfolio turnover was 12%.

C000091238 Fees and Expenses

Annual operating expenses and sales charges of C000091238. Prospectus, as of October 31, 2025.

Annual operating expenses
Management fee0.32%
12b-1 fee—
Other expenses0.05%
Gross expense ratio0.56%
Fee waiver−0.19%
Net expense ratio0.37%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

C000091238 Costs Over Time

On $10,000 invested in C000091238, assuming 5% a year before costs, total costs come to $234 over 5 years, cutting the return by 0.39% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.37%)$39$122$213
Lost growth on money paid in costs$0$6$21
Total costs$39$128$234
Value after costs$10,461$11,448$12,528
Impact on return, per year0.39%0.39%0.39%

C000091238 Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: $124
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 12%
  • Securities on loan, average value: $14.8M
  • Net income from securities lending: $198K (0.061% of average net assets)

C000091238 Agency Brokers

Commissions paid.

BrokerAmountShare
Citigroup Global Markets Inc.$124100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.